Alemtuzumab in Lung Transplantation: An Open-Label, Randomized, Prospective Single Center Study-Reference-Cited by-同舟云学术

Alemtuzumab in Lung Transplantation: An Open-Label, Randomized, Prospective Single Center Study

Author:

Jaksch P.¹,Ankersmit J.¹,Scheed A.¹,Kocher A.²,Muraközy G.¹,Klepetko W.¹,Lang G.¹

Affiliation:

1. Department of Thoracic Surgery; Medical University of Vienna; Wien Austria

2. Department of Cardiac Surgery; Medical University of Vienna; Wien Austria

Funder

Astellas Pharma Austria

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

Reference19 articles.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Transplant Rejection;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

2. Post‐Transplant Phase: Issues in the Early Postoperative Period;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. Clinical Trials in Lung Transplantation;Organ and Tissue Transplantation;2023